State Street Corp Raises Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

State Street Corp raised its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 17.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 667,868 shares of the company's stock after buying an additional 99,244 shares during the period. State Street Corp owned approximately 4.42% of U.S. Physical Therapy worth $56,522,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Renaissance Technologies LLC raised its holdings in U.S. Physical Therapy by 763.7% in the second quarter. Renaissance Technologies LLC now owns 69,523 shares of the company's stock valued at $6,425,000 after acquiring an additional 61,474 shares in the last quarter. Penn Davis Mcfarland Inc. acquired a new position in shares of U.S. Physical Therapy during the third quarter worth $2,552,000. Rockefeller Capital Management L.P. increased its holdings in U.S. Physical Therapy by 18.8% in the third quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company's stock valued at $13,578,000 after buying an additional 25,393 shares during the last quarter. BNP Paribas Financial Markets raised its stake in U.S. Physical Therapy by 283.0% in the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company's stock valued at $1,425,000 after buying an additional 12,445 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of U.S. Physical Therapy by 2.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company's stock worth $39,173,000 after acquiring an additional 10,462 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on USPH shares. JPMorgan Chase & Co. upped their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a report on Tuesday, December 3rd. Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday. JMP Securities started coverage on shares of U.S. Physical Therapy in a research note on Monday. They issued an "outperform" rating and a $113.00 price objective for the company. Bank of America raised U.S. Physical Therapy from a "neutral" rating to a "buy" rating and boosted their target price for the company from $100.00 to $115.00 in a report on Monday. Finally, Barrington Research reaffirmed an "outperform" rating and set a $108.00 price target on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $114.00.

Insider Activity at U.S. Physical Therapy

In other news, insider Eric Joseph Williams sold 2,000 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $95.84, for a total value of $191,680.00. Following the sale, the insider now directly owns 14,814 shares in the company, valued at $1,419,773.76. This represents a 11.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares of the company's stock, valued at $1,970,141.25. This represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 7,412 shares of company stock valued at $706,605 in the last ninety days. Corporate insiders own 1.70% of the company's stock.

U.S. Physical Therapy Price Performance

Shares of NYSE:USPH traded down $1.02 on Thursday, reaching $91.41. 96,138 shares of the company were exchanged, compared to its average volume of 93,970. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 1-year low of $76.18 and a 1-year high of $113.63. The company has a 50-day moving average of $90.30 and a 200-day moving average of $89.82. The firm has a market cap of $1.38 billion, a price-to-earnings ratio of 97.24, a price-to-earnings-growth ratio of 4.23 and a beta of 1.46.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were paid a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.93%. The ex-dividend date of this dividend was Friday, November 15th. U.S. Physical Therapy's payout ratio is currently 187.23%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.